SRPT
NASDAQ · Biotechnology
Sarepta Therapeutics Inc
$20.48
+0.34 (+1.69%)
Open$20.47
Previous Close$20.14
Day High$20.48
Day Low$20.46
52W High$25.32
52W Low$14.68
Volume—
Avg Volume3.00M
Market Cap2.18B
P/E Ratio—
EPS$-1.82
SectorBiotechnology
Analyst Ratings
Hold
33 analysts
Price Target
+94.3% upside
Current
$20.48
$20.48
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.38B | 1.79B | 549.72M |
| Net Income | -772,126,486 | -522,216,756 | -107,586,925 |
| Profit Margin | -32.5% | -30.8% | -19.6% |
| EBITDA | -736,291,495 | -525,645,840 | -125,300,242 |
| Free Cash Flow | — | — | -79,607,758 |
| Rev Growth | +33.1% | +33.1% | +15.5% |
| Debt/Equity | 0.73 | 0.73 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |